{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:41:16Z","timestamp":1783525276992,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>People can acquire <jats:italic>Toxoplasma gondii<\/jats:italic> infection by ingestion of sporulated oocysts passed in cat feces; whether this route is common in cats is unknown. The primary objectives of this study were to (a) adapt a commercially available enzyme-linked immunosorbent assay (ELISA) for the detection of <jats:italic>T. gondii<\/jats:italic> tachyzoite IgG antibodies in feline sera to detect <jats:italic>T. gondii<\/jats:italic> sporozoite IgG antibodies, (b) utilize the ELISA to confirm that exposed cats can mount an antibody response to sporozoites, (c) estimate the prevalence of sporozoite antibodies in naturally exposed cats, and (d) evaluate associations between the serologic status of naturally exposed cats and clinical signs that could be caused by toxoplasmosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To generate positive control sera, three male cats were orally inoculated with approximately 100,000 sporulated oocysts of the ME49 strain of <jats:italic>T. gondii<\/jats:italic>. A human antisporozoite antibody ELISA was then adapted for use with cat sera. Detectable levels of antisporozoite IgG were found in two of the three experimentally inoculated cats. The sera of 100 healthy cats and 295 clinically ill cats were assessed in the prototype sporozoite ELISA and a commercially available tachyzoite ELISA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The ELISA estimated that prevalence of antisporozoite IgG was 2% in healthy cats and 3.1% in clinically ill cats; in contrast, the overall estimated prevalence of antitachyzoite IgG was 15%. Only two of 395 cats (0.5%) had both antisporozoite and antitachyzoite IgG.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>While experimentally infected and naturally exposed cats developed antisporozoite antibodies, the low prevalence did not allow for the evaluation of associations among clinical signs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13071-024-06553-6","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T09:08:35Z","timestamp":1733130515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating the significance of Toxoplasma gondii sporozoite antibodies in cats: a pilot study"],"prefix":"10.1186","volume":"17","author":[{"given":"Janelle","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianne","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Valeria","family":"Scorza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michala","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lappin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"6553_CR1","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/j.1469-0691.2007.01771.x","volume":"13","author":"P Kolbekova","year":"2007","unstructured":"Kolbekova P, Kourbatova E, Novotna M, Kodym P, Flegr J. New and old risk-factors for Toxoplasma gondii infection: prospective cross-sectional study among military personnel in the Czech Republic. Clin Microbiol Infect. 2007;13:1012\u20137.","journal-title":"Clin Microbiol Infect"},{"key":"6553_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1053\/j.tcam.2010.07.002","volume":"25","author":"MR Lappin","year":"2010","unstructured":"Lappin MR. Update on the diagnosis and management of Toxoplasma gondii infection in cats. Top Companion Anim Med. 2010;25:136\u201341.","journal-title":"Top Companion Anim Med"},{"key":"6553_CR3","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.ijpara.2008.03.007","volume":"38","author":"J Dubey","year":"2008","unstructured":"Dubey J, Jones J. Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol. 2008;38:1257\u201378.","journal-title":"Int J Parasitol"},{"key":"6553_CR4","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ijpara.2009.01.005","volume":"39","author":"JP Dubey","year":"2009","unstructured":"Dubey JP. History of the discovery of the life cycle of Toxoplasma gondii. Int J Parasitol. 2009;39:877\u201382.","journal-title":"Int J Parasitol"},{"key":"6553_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0304-4017(01)00521-0","volume":"102","author":"CC Powell","year":"2001","unstructured":"Powell CC, Brewer M, Lappin MR. Detection of Toxoplasma gondii in the milk of experimentally infected lactating cats. Vet Parasitol. 2001;102:29\u201333.","journal-title":"Vet Parasitol"},{"key":"6553_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1645\/GE-2782.1","volume":"97","author":"D Hill","year":"2011","unstructured":"Hill D, Coss C, Dubey JP, Wroblewski K, Sautter M, Hosten T, et\u00a0al. Identification of a sporozoite-specific antigen from Toxoplasma gondii. J Parasitol. 2011;97:328\u201337.","journal-title":"J Parasitol"},{"key":"6553_CR7","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3201\/eid1610.091674","volume":"16","author":"CA Mu\u00f1oz-Zanzi","year":"2010","unstructured":"Mu\u00f1oz-Zanzi CA, Fry P, Lesina B, Hill D. Toxoplasma gondii oocyst\u2013specific antibodies and source of infection. Emerg Infect Dis. 2010;16:1591\u20133.","journal-title":"Emerg Infect Dis"},{"key":"6553_CR8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1177\/1098612X13489228","volume":"15","author":"K Hartmann","year":"2013","unstructured":"Hartmann K, Addie D, Bel\u00e1k S, Boucraut-Baralon C, Egberink H, Frymus T, et\u00a0al. Toxoplasma gondii infection in cats: ABCD guidelines on prevention and management. J Feline Med Surg. 2013;15:631\u20137.","journal-title":"J Feline Med Surg"},{"key":"6553_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.vetpar.2006.03.018","volume":"140","author":"JP Dubey","year":"2006","unstructured":"Dubey JP. Comparative infectivity of oocysts and bradyzoites of Toxoplasma gondii for intermediate (mice) and definitive (cats) hosts. Vet Parasitol. 2006;140:69\u201375.","journal-title":"Vet Parasitol"},{"key":"6553_CR10","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2307\/3284206","volume":"82","author":"JP Dubey","year":"1996","unstructured":"Dubey JP. Infectivity and pathogenicity of Toxoplasma gondii oocysts for cats. J Parasitol. 1996;82:957\u201361.","journal-title":"J Parasitol"},{"key":"6553_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/0035-9203(71)90018-6","volume":"65","author":"WM Hutchison","year":"1971","unstructured":"Hutchison WM, Dunachie JF, Work K, Siim JC. The life cycle of the coccidian parasite, Toxoplasma gondii, in the domestic cat. Trans R Soc Trop Med Hyg. 1971;65:380\u201398.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"6553_CR12","doi-asserted-by":"publisher","first-page":"874","DOI":"10.2460\/ajvr.2005.66.874","volume":"66","author":"MR Vollaire","year":"2005","unstructured":"Vollaire MR, Radecki SV, Lappin MR. Seroprevalence of Toxoplasma gondii antibodies in clinically ill cats in the United States. Am J Vet Res. 2005;66:874\u20137.","journal-title":"Am J Vet Res"},{"key":"6553_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2460\/ajvr.76.4.351","volume":"76","author":"MR Lappin","year":"2015","unstructured":"Lappin MR, VanLare KA, Seewald W, Roycroft LM, Scorza AV, King S, et\u00a0al. Effect of oral administration of cyclosporine on Toxoplasma gondii infection status of cats. Am J Vet Res. 2015;76:351\u20137.","journal-title":"Am J Vet Res"},{"key":"6553_CR14","unstructured":"Dean A, Sullivan K, Soe M. OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version [Internet]. 2013. www.openepi.com. Accessed 1 Aug 2024"},{"key":"6553_CR15","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.2460\/javma.231.11.1676","volume":"231","author":"HA Dabritz","year":"2007","unstructured":"Dabritz HA, Miller MA, Atwill ER, Gardner IA, Leutenegger CM, Melli AC, et\u00a0al. Detection of Toxoplasma gondii-like oocysts in cat feces and estimates of the environmental oocyst burden. J Am Vet Med Assoc. 2007;231:1676\u201384.","journal-title":"J Am Vet Med Assoc"},{"key":"6553_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1939-1676.2001.tb02294.x","volume":"15","author":"CV Spain","year":"2001","unstructured":"Spain CV, Scarlett JM, Wade SE, McDonough P. Prevalence of enteric zoonotic agents in cats less than 1 year old in central New York State. J Vet Intern Med. 2001;15:33\u20138.","journal-title":"J Vet Intern Med"},{"key":"6553_CR17","doi-asserted-by":"publisher","first-page":"865","DOI":"10.4269\/ajtmh.2010.09-0635","volume":"82","author":"H Salant","year":"2010","unstructured":"Salant H, Hamburger J, Spira DT. A comparative analysis of coprologic diagnostic methods for detection of Toxoplama gondii in Cats. Am J Trop Med Hyg. 2010;82:865\u201370.","journal-title":"Am J Trop Med Hyg"},{"key":"6553_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1674-8301(11)60001-8","volume":"25","author":"GJ Leitch","year":"2012","unstructured":"Leitch GJ, He Q. Cryptosporidiosis-an overview. J Biomed Res. 2012;25:1\u201316.","journal-title":"J Biomed Res"},{"key":"6553_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/fty056\/5037924","author":"DS Ashour","year":"2018","unstructured":"Ashour DS, Saad AE, El Bakary RH, El Barody MA. Can the route of Toxoplasma gondii infection affect the ophthalmic outcomes? Pathog Dis. 2018;76(5). https:\/\/doi.org\/10.1093\/femspd\/fty056\/5037924.","journal-title":"Pathog Dis"},{"key":"6553_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.01305\/abstract","author":"SS Santana","year":"2015","unstructured":"Santana SS, Gebrim LC, Carvalho FR, Barros HS, Barros PC, Pajuaba ACAM, et\u00a0al. CCp5A Protein from Toxoplasma gondii as a Serological marker of oocyst-driven infections in humans and domestic animals. Front Microbiol. 2015;6:1305. https:\/\/doi.org\/10.3389\/fmicb.2015.01305\/abstract.","journal-title":"Front Microbiol"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-024-06553-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-024-06553-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-024-06553-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T10:06:05Z","timestamp":1733133965000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-024-06553-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6553"],"URL":"https:\/\/doi.org\/10.1186\/s13071-024-06553-6","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"27 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project was approved by the Institutional Animal Care and Use Committee (protocol 17-7341A). No human subjects were involved in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"497"}}